CKBBT - STAR BRITE ANTI-FREEZE

Product Identification

Product ID:STAR BRITE ANTI-FREEZE
MSDS Date:05/14/1999
FSC:6850
NIIN:01-441-3234
Status Code:A
MSDS Number: CKBBT

Responsible Party
STAR BRITE DISTRIBUTING, INC
4041 S W 47 AVE
FT LAUDERDALE, FL 33314
US

Emergency Phone: 800-424-9300

Info Phone: 305-587-6280

Cage: 0GR42

Contractor
STAR BRITE DISTRIBUTING INC
FORT LAUDERDALE, FL 33314-4023 US

Telephone: 954-587-6280

Cage: 0GR42

Ingredients

ETHYLENE GLYCOL

CAS: 107-21-1

RTECS: KW2975000

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB


WATER

CAS: 7732-18-5

RTECS: ZC0110000


DIETHYLENE GLYCOL

CAS: 111-46-6

RTECS: ID5950000


INORGANIC/ORGANIC SALTS

Hazards

LD50 LC50 Mixture:NOT LISTED FOR WHOLE PRODUCT
Health Hazards Acute and Chronic:EYE-BASED ON PRESENCE OF COMPONENT 1,
PRODUCT IS MODERATELY TO SEVERELY IRRITATING TO THE EYES, VAPORS
CAN ALSO CAUSE SEVERE EYE IRRITATION. SKIN-BASED ON PRESENCE OF
COMPONENTS 1 AND 2, PRODUCT IS MI LDLY IRRITATING TO THE SKIN AND
SLIGHTLY TOXIC ON PROLONGED OR REPEATED CONTACT. INHALATION-VAPORS
ARE MILDLY TO MARKEDLY IRRITATING TO THE LUNGS DEPENDING ON THE
EXPOSURE LEVEL. INGESTION-PRODUCT MAY BE HARMFUL OR FATAL IF
SWALLOWED; MAY PRODUCE CENTRAL NERVOUS SYSTEM (CNS) DEPRESSION AND
KIDNEY DAMAGE WHICH MAY BE FATAL. INGESTION OF COMPONENT 2 MAY ALSO
PRODUCE LIVER DAMAGE.
Explanation of Carcinogenicity:NONE SPECIFIED BY RESPONSIBLE PARTY.
Effects of Overexposure:IRRITATION AS NOTED ABOVE. EARLY TO MODERATE
CNS DEPRESSION MAY BE EVIDENCED BY GIDDINESS, HEADACHE, DIZZINESS
AND NAUSEA, IN EXTREME CASES, UNCONSCIOUSNESS AND DEATH MAY OCCUR.
KIDNEY DAMAGE MAY BE E VIDENCED BY CHANGES IN URINE OUPUT, URINE
APPEARANCE OR EDEMA(SWELLING FROM FLUID RETENTION). LIVER DAMAGE
MAY BE EVIDENCED BY LOSS OF APPETITE, JAUNDICE(YELLOWISH SKIN
COLOR) AND SOMETIMES PAIN IN TH E UPPER ABDOMEN ON THE RIGHT
SIDE.INTENTIONAL ABUSE, MISUSE OR OTHER MASSIVE EXPOSURE MAY CAUSE
MULTIPLE ORGAN DAMAGE AND/OR HEALTH.
Medical Cond Aggravated by Exposure:PREEXISTING SKIN, EYE AND
RESPIRATORY DISORDERS MAY BE AGGRAVATED BY EXPOSURE TO THIS
PRODUCT. IMPAIRED KIDNEY & LIVER FUNCTIONS FROM PREEXISTING
DISORDERS MAY BE AGGRAVATED BY EXPOSURE TO THIS PRODUCT.

First Aid

First Aid:EYE-IMMEDIATELY FLUSH EYES WITH PLENTY OF WATER FOR AT LEAST
15 MINUTES WHILE HOLDING EYELIDS OPEN. GET MEDICAL ATTENTION.
SKIN-FLUSH SKIN WITH WATER. IF IRRITATION OCCURS, GET MEDICAL
ATTENTION. INHA LATION-REMOVE VICTIM TO FRESH AIR AND PROVIDE
OXYGEN IF BREATHING IS DIFFICULT. GET MEDICAL ATTENTION.
INGESTION-DO NOT GIVE LIQUIDS IF VICTIM IS UNCONSCIOUS OR VERY
DROWSY. OTHERWISE, GIVE NO MORE TH AN 2 GLASSES OF WATER AND INDUCE
VOMITING BY GIVING 30CC(2TABLESPOONS) SYRUP OF IPECAC. IF IPECAC IS
UNAVAILABLE, GIVE 2 GLASSES OF WATER AND INDUCE VOMITING BY
TOUCHING FINGER TO BACK OF VICTIM'S THR OAT.

Fire Fighting

Flash Point Method:SCC
Flash Point:=118.9C, 246.F
Lower Limits:N/AP
Upper Limits:N/AP
Extinguishing Media:USE WATER FOG, "ALCOHOL" FOAM, DRY CHEMICAL OR
CARBON DIOXIDE (CO2).
Fire Fighting Procedures:DO NOT ENTER CONFINED FIRE SPACE WITHOUT FULL
BUNKER GEAR(HELMET WITH FACE SHIELD, BUNKER COATS, GLOVES AND
RUBBER BOOTS), INCLUDING A POSITIVE PRESSURE NIOSH APPROVED
SELF-CONTAINED BREATHING APPARAT US. COOL FIRE EXPOSED CONTAINERS
WITH WATER.
Unusual Fire/Explosion Hazard:MATERIAL WILL NOT BURN UNLESS PREHEATED.

Accidental Release

Spill Release Procedures:LARGE SPILLS-WEAR RESPIRATORS AND PROTECTIVE
CLOTHING AS APPROPRIATE. SHUT OFF SOURCE OF LEAK IF SAFE TO DO SO.
DIKE AND CONTAIN. REMOVE VACUUM TRUCKS OR PUMP TO STORAGE/SALVAGE
VESSELS. SOAK UP RESID UE WITH AN ABSORBENT SUCH AS CLAY, SAND OR
OTHER SUITABLE MATERIAL. DISPOSE OF PROPERLY.SMALL SPILLS- TAKE UP
WITH AN ABSORBENT MATERIAL AND DISPOSE OF PROPERLY.
Neutralizing Agent:NONE SPECIFIED BY RESPONSIBLE PARTY.

Handling

Handling and Storage Precautions:STORE IN COOL,DRY PLACE WITH ADEQUATE
VENTILATION. KEEP AWAY FROM FLAMES AND HIGH TEMPERATURES.
Other Precautions:WASH WITH SOAP AND WATER BEFORE EATING, DRINKING,
SMOKING OR USING TOILET FACILITIES. LAUNDER CONTAMINATED CLOTHING
BEFORE REUSE.

Exposure Controls

Respiratory Protection:IF EXPOSURE MAY OR DOES EXCEED OCCUPATIONAL
EXPOSURE LIMITS (SEC.IV) USE A NIOSH-APPROVED RESPIRATOR TO PREVENT
OVEREXPOSURE, IN ACCORDANCE WITH 29 CFR 1910.134 USE EITHER AN
ATMOSPHERE-SUPPLYING RES PIRATOR OR AN AIR-PURIFYING RESPIRATOR FOR
ORGANIC VAPORS.
Ventilation:USE VENTILATION AS REQUIRED TO CONTROL VAPOR CONCENTRATION.
Protective Gloves:NITRILE,NEOPRENE, PVC OR NATURAL RUBBER GLOVES.
Eye Protection:CHEMICAL GOGGLES.
Other Protective Equipment:WEAR CHEMICAL RESISTANT CLOTHING AS
REQUIRED TO MINIMIZE CONTACT.
Work Hygienic Practices:EYE WASH FOUNTAINS AND SAFETY SHOWERS SHOULD BE
AVAILABLE FOR EMERGENCY USE. AVOID CONTACT WITH EYES. AVOID
PROLONGED OR REPEATED CONTACT WITH SKIN.
Supplemental Safety and Health
NOTE TO PHYSICIAN-IF VICTIM IS A CHILD, GIVE NO MORE THAN 1 GLASS OF
WATER AND 15CC (1TABLESPOON) OF SYRUP OF IPECAC. IF SYMPTOMS SUCH
AS LOSS OF GAG REFLEX, CONVULSIONS OR UNCONSCIOUSNESS OCCUR BEFOR E
EMESIS, GASTRIC LAVAGE SHOULD BE CONSIDERED FOLLOWING INTUBATION
WITH A CUFFED ENDOTRACHEAL TUBE.

Chemical Properties

HCC:V5
Boiling Pt:=111.1C, 232.F
Vapor Density:>1
Spec Gravity:1.0750
pH:8.5-9.5
Evaporation Rate & Reference:<0.01
Solubility in Water:COMPLETE
Appearance and Odor:COLORLESS TO GREEN, SLIGHTLY VISCOUS LIQUID. MILD
ODOR.

Stability

KEEP AWAY FROM STRONG OXIDIZING AGENTS.
Stability Condition to Avoid:KEEP AWAY FROM STRONG OXIDIZING AGENTS.
Hazardous Decomposition Products:CARBON MONOXIDE AND UNIDENTIFIED
ORGANIC COMPOUNDS MAY BE FORMED DURING COMBUSTION.
Conditions to Avoid Polymerization:WILL NOT OCCUR.

Disposal

Waste Disposal Methods:NONE SPECIFIED BY RESPONSIBLE PARTY.

Toxicology

Toxicological Information:RARE CASE REPORTS OF ETHYLENE GLYCOL
SENSITIZATION (ALLERGY) HAVE BEEN PUBLISHED BUT ALLERGY TO ETHYLENE
GLYCOL IS NOT A COMMON PHENOMENON. DIETHYLENE GLYCOL GIVEN ORALLY
AT HIGH DOSES TO PREGNANT RAT S & MICE CAUSED TOXICITY TO THE
EMBRYOFETUS INCLUDING DECREASED FETAL BODY WEIGHTS & INCREASED
VARIATIONS. BUT NO BIRTH DEFECTS WERE OBSERVED. THERE WAS EVIDENCE
OF MATERNAL TOXICTY (A DIFFERENT STUDY ) IN TREATED ANIMALS. THE
SIGNIFIGANCE OF THIS INFORMATION TO MAN IS UNKNOWN.

Other Information

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecology

Ecological:NONE SPECIFIED BY RESPONSIBLE PARTY.

Transport

Transport Information:REGULATED ONLY IN PACKAGES THAT CONTAIN 5000 LBS
OR MORE OF ETHYLENE GLYCOL.

Regulatory

SARA Title III Information:SECTION 313: YES. 311/312 CATAGORIES:
IMMEDIATE/ACUTE-YES; DELAYED/CHRONIC-YES. EHS RQ/EHS TPQ=NONE.
Federal Regulatory Information:THE REPORTABLE QUANTITY (RQ): 5,319 LBS
(BASED ON ETHYLENE GLYCOL).
State Regulatory Information:ETHYLENE GLYCOL, CAS# 107-21-1 LISTED BY
THE FOLLOWING STATES: CA, CT, FL, IL, LA, MA, ME, MN, NJ, PA, RI.